"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","cell type:ch1","tissue:ch1"
"GSM1563104","exosomal miR BM01","GSM1563104","Public on Feb 01 2016","Dec 10 2014","Feb 01 2016","RNA","1","Healthy volunteer","Homo sapiens","tissue: Bone marrow","cell type: Normal BM CD34+ cells","5 mL of supernatant was harvested. Exosomes were isolated by Exosome Precipitation Solution (ExoQuick-TC; System Biosciences, Mountain View, CA).","Two hundred thausand of primary nomal BM or AML CD34+ cells were cultured on fibronectin-coated dish in the presence of cytokines including SCF, TPO, FL and Delta-like protein 4 for 7 days.","total RNA","RNAs were extracted from samples using 3D-Gene RNA extraction reagent from liquid sample (Toray, Kamakura, Japan)","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray, Kamakura, Japan)","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","Bone marrow CD34+ cell","Exosomal microRNA released from CD34+ fraction of primary BM cells.","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","New Projects Development Division","Toray Industries,Inc.","Tebiro 6-10-1","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1563nnn/GSM1563104/suppl/GSM1563104_SH45T47_1.txt.gz","2555","Normal BM CD34+ cells","Bone marrow"
"GSM1563105","exosomal miR Pt01","GSM1563105","Public on Feb 01 2016","Dec 10 2014","Feb 01 2016","RNA","1","Leukemia patient","Homo sapiens","tissue: Bone marrow","cell type: CD34+ fraction of leukemic cells","5 mL of supernatant was harvested. Exosomes were isolated by Exosome Precipitation Solution (ExoQuick-TC; System Biosciences, Mountain View, CA).","Two hundred thausand of primary nomal BM or AML CD34+ cells were cultured on fibronectin-coated dish in the presence of cytokines including SCF, TPO, FL and Delta-like protein 4 for 7 days.","total RNA","RNAs were extracted from samples using 3D-Gene RNA extraction reagent from liquid sample (Toray, Kamakura, Japan)","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray, Kamakura, Japan)","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","AML M1","Exosomal microRNA released from CD34+ fraction of leukemic cells","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","New Projects Development Division","Toray Industries,Inc.","Tebiro 6-10-1","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1563nnn/GSM1563105/suppl/GSM1563105_SH46324_1.txt.gz","2555","CD34+ fraction of leukemic cells","Bone marrow"
"GSM1563106","exosomal miR Pt02","GSM1563106","Public on Feb 01 2016","Dec 10 2014","Feb 01 2016","RNA","1","Leukemia patient","Homo sapiens","tissue: Bone marrow","cell type: CD34+ fraction of leukemic cells","5 mL of supernatant was harvested. Exosomes were isolated by Exosome Precipitation Solution (ExoQuick-TC; System Biosciences, Mountain View, CA).","Two hundred thausand of primary nomal BM or AML CD34+ cells were cultured on fibronectin-coated dish in the presence of cytokines including SCF, TPO, FL and Delta-like protein 4 for 7 days.","total RNA","RNAs were extracted from samples using 3D-Gene RNA extraction reagent from liquid sample (Toray, Kamakura, Japan)","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray, Kamakura, Japan)","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","AML M4　","Exosomal microRNA released from CD34+ fraction of leukemic cells","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","New Projects Development Division","Toray Industries,Inc.","Tebiro 6-10-1","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1563nnn/GSM1563106/suppl/GSM1563106_SH45T47_2.txt.gz","2555","CD34+ fraction of leukemic cells","Bone marrow"
